首页> 外文期刊>ABCD. Arquivos Brasileiros de Cirurgia Digestiva (So Paulo) >DO PROXIMAL AND DISTAL GASTRIC TUMOURS BEHAVE DIFFERENTLY?
【24h】

DO PROXIMAL AND DISTAL GASTRIC TUMOURS BEHAVE DIFFERENTLY?

机译:近端和远端胃肿瘤表现得不同吗?

获取原文
       

摘要

Background: Although the incidence of gastric (adenocarcinoma) cancer has been decreasing over time, it is still one of the most common malignancies worldwide, and proximal tumours tend to have a worse prognosis. Aim: To compare surgical outcomes and prognosis between proximal - excluding tumours of the cardia - and distal gastric cancer. Methods: Out of 293 cases reviewed - 209 with distal and 69 with proximal gastric cancer - were compared for clinical and pathological features, stage, surgical outcome, mortality and survival. Results: Statistically, there was no significant difference between patients in both groups regarding mortality (p=0.661), adjuvant chemotherapy (p 0.661), and radiation (p=1.000). However, there was significant difference in the degree of lymph node dissection employed (p=0.002) and the number of positive lymph nodes resected (p=0.038) between the two groups. The odds of death at five years for patients who had a D0 dissection was three times greater (odds ratio 2.78; (95%CI 1.33-5.82) than that for patients who had a D2 dissection, while for patients who had a D1 dissection the odds ratio was only 1.41 (95%CI 0.71-2.83) compared to D2-dissected patients. Conclusion: Although no significant differences were found between proximal and distal gastric cancer, the increased risk of death in D0- and D1-dissected patients clearly suggests an important role of radical D2 lymph node dissection in survival.
机译:背景:虽然胃(腺癌)癌症的发病率随着时间的推移已经减少,但它仍然是全球最常见的恶性肿瘤之一,近端肿瘤往往具有更糟糕的预后。目的:比较涉及贲门和远端胃癌近端肿瘤的外科结果和预后。方法:在临床和病理特征,阶段,手术结果,死亡率和生存中比较了293例 - 209例 - 209例 - 209例 - 209例,患有近端胃癌的患者和69例。结果:统计上,两组患者对死亡率(P = 0.661),佐剂化疗(P 0.661)和辐射(P = 1.000)之间没有显着差异。然而,所用淋巴结剖面的程度(p = 0.002)和两组之间切除的阳性淋巴结数(p = 0.038)的阳性淋巴结的数量存在显着差异。对于具有D2解剖的患者的患者为5岁的患者死亡的几率(达赔比例为2.78),而是对于具有D2解剖的患者,对于具有D1解剖的患者而言与D2患者相比,差距仅为1.41(95%CI 0.71-2.83)。结论:虽然在近端和远端胃癌之间没有发现显着差异,但D0和D1患者的死亡风险增加明确表明自由基D2淋巴结清除在存活中的重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号